These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7816742)

  • 1. Protective effects of BAY U 3405, a thromboxane A2 receptor antagonist, in endotoxin shock.
    Altavilla D; Canale P; Squadrito F; Sardella A; Ammendolia L; Urna G; Ioculano M; Squadrito G; Caputi AP
    Pharmacol Res; 1994; 30(2):137-51. PubMed ID: 7816742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of BAY u3405, a novel thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Campo GM; Squadrito G; Urna G; Sardella A; Caputi AP
    Pharmacology; 1994 Dec; 49(6):376-85. PubMed ID: 7878075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-alpha biosynthesis.
    Altavilla D; Squadrito F; Canale P; Ioculano M; Squadrito G; Campo GM; Serranò M; Sardella A; Urna G; Spignoli G
    Eur J Pharmacol; 1995 Nov; 286(1):31-9. PubMed ID: 8566149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane-blocked swine as an experimental model of severe intravascular inflammation and septic shock.
    Jesmok G; Gundel R
    Shock; 1995 Nov; 4(5):379-83. PubMed ID: 8595527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
    Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
    Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of myocardial leukocyte accumulation and myocardial infarct size following administration of BAY u3405, a thromboxane A2 receptor antagonist, in myocardial ischaemia-reperfusion injury.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Faggiotto A; Caputi AP
    Agents Actions; 1993 Jul; 39(3-4):143-9. PubMed ID: 8304242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the thromboxane receptor antagonist, BM 13.505, on the sequelae of endotoxemia in the conscious rat.
    Smith EF; Jugus M; Kinter LB
    Eicosanoids; 1988; 1(1):27-33. PubMed ID: 3078574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloricromene, a coumarine derivative, protects against lethal endotoxin shock in rats.
    Squadrito F; Altavilla D; Campo GM; Calapai G; Ioculano M; Zingarelli B; Saitta A; Prosdocimi M; Caputi AP
    Eur J Pharmacol; 1992 Jan; 210(2):107-13. PubMed ID: 1601052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental study on the pathophysiology of endotoxin shock as analysed by alterations in thromboxane B2 and 6-keto-PGF1 alpha levels].
    Baba H
    Nihon Geka Gakkai Zasshi; 1988 Jan; 89(1):6-20. PubMed ID: 3283521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of G 619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, in splanchnic artery occlusion shock.
    Squadrito F; Altavilla D; Zingarelli B; Ioculano MP; Campo GM; Calapai G; Saitta A; Urna G; Sardella A; Spignoli G
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):115-9. PubMed ID: 1375677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, reduces myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion in rats.
    Squadrito F; Ioculano M; Altavilla D; Zingarelli B; Canale P; Campo GM; Saitta A; Oriti S; Spignoli G; Caputi AP
    Pharmacology; 1993 Sep; 47(3):167-75. PubMed ID: 8415867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of ONO 3708, a new thromboxane A2 receptor antagonist, during experimental endotoxin shock.
    Taneyama C; Sasao J; Senna S; Kimura M; Kiyono S; Goto H; Arakawa K
    Circ Shock; 1989 May; 28(1):69-77. PubMed ID: 2525079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Zingarelli B; Campo GM; Urna G; Sardella A; Squadrito G; Caputi AP
    Agents Actions; 1994 Oct; 42(3-4):128-34. PubMed ID: 7879698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet activating factor involvement in splanchnic artery occlusion shock in rats.
    Squadrito F; Sturniolo R; Altavilla D; Santoro G; Campo GM; Arena A; Caputi AP
    Eur J Pharmacol; 1991 Jan; 192(1):47-53. PubMed ID: 2040364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of the protective action of Bay-u-3405, a new specific thromboxane receptor antagonist, in arachidonate-induced sudden death.
    Ma XL; Karasawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1991 Mar; 13(2):105-10. PubMed ID: 1906568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli.
    Huang Y; Wang SR; Yi C; Ying MY; Lin Y; Zhi MH
    World J Gastroenterol; 2002 Dec; 8(6):1134-7. PubMed ID: 12439940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of trans-13-APT, a thromboxane receptor antagonist, in endotoxemia.
    Olanoff LS; Cook JA; Eller T; Knapp DR; Halushka PV
    J Cardiovasc Pharmacol; 1985; 7(1):114-20. PubMed ID: 2580129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the beneficial effects of aspirin in endotoxic shock. Relationship to inhibition of arachidonic acid metabolism.
    Halushka PV; Wise WC; Cook JA
    Am J Med; 1983 Jun; 74(6A):91-6. PubMed ID: 6687979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arachidonic acid metabolism in endotoxin tolerance.
    Wise WC; Cook JA; Halushka PV
    Adv Shock Res; 1983; 10():131-42. PubMed ID: 6410699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.